Trade OCS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Oculis Holding AG (OCS) is trading at US$12.17, up 0.00% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$726.58M. Over the past 52 weeks, OCS has traded between US$10.52 and US$34.48. On Syfe you can trade OCS with $0 commission and add it to your watchlist.
| Previous close | US$12.17 |
|---|---|
| Market cap | US$726.58M |
| 52-week range | US$10.52 – US$34.48 |
| Volume | 124.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Oculis Holding AG
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Year: 2023
Top Premarket Decliners
Jun 1, 11:36 AM · MT Newswires
Oculis Holding AG Phase 3 Trial of Potential Eye Drops for Diabetic Patients Fails to Primary Endpoint
May 29, 7:46 PM · MT Newswires
Guggenheim Initiates Oculis Holding at Buy With $75 Price Target
May 21, 11:12 AM · MT Newswires
Oculis Holding AG (OCS) stock is trading at US$12.17, 0.00% from the previous close of US$12.17.
The market cap for Oculis Holding AG (OCS) stock is approximately US$726.58M.
The 52-week high for Oculis Holding AG (OCS) stock is US$34.48.
The 52-week low for Oculis Holding AG (OCS) stock is US$10.52.
Oculis Holding AG (OCS) does not currently pay a dividend.
Stay on top of OCS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
